News | Radiation Therapy | July 03, 2017

IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market

Companies plan to escalate joint sales and marketing activities in the region

IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market

July 3, 2017 — IBA and Philips announced in mid-June they are stepping up their combined effort for proton therapy in Brazil.

Both companies agreed to escalate joint sales and marketing activities in Brazil, for the promotion of Philips's imaging and clinical informatics solutions in oncology, and IBA's proton therapy solutions. The agreement merges their respective expertise in image guidance and therapy with the ultimate objective of enabling more effective and personalized cancer care.
 
The Brazilian market for superior medical imaging solutions and advanced forms of radiotherapy treatment such as proton therapy is a key focus for both partners. The commercial collaboration between Philips and IBA has already led to the successful execution of proton therapy contracts in Europe, Asia and the Middle-East.
 
The two companies offer unique integrated solutions for proton therapy and molecular imaging centers. They are currently installing state-of-the-art proton therapy solutions at three compact proton therapy centers in the U.K., one compact center in the Middle East, and one large proton therapy center in India. Depending on the proton therapy center, the installed solution can include IBA’s proton therapy systems, such as; the Proteus One and Proteus Plus, and Philips’ imaging and clinical informatics solutions, such as Philips’ Big Bore CT (computed tomography) and positron emission tomography (PET)/CT systems and Philips’ Pinnacle3 Treatment Planning System.

For more information: www.iba-worldwide.com, www.usa.philips.com/healthcare

Related Content

Mirada Medical Releases DLCExpert for Radiotherapy Treatment Planning
Technology | Treatment Planning | February 22, 2018
February 22, 2018 — U.K.-based medical imaging software provider Mirada Medical has released DLCExpert, the first com
Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning
News | Treatment Planning | February 16, 2018
The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
Varian Signs Agreement to Acquire Sirtex
News | Radiation Therapy | January 31, 2018
January 31, 2018 — Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares

This PET/CT shows metastasis of tumors, taken with the Philips TruFlight Select.

Feature | Radiation Oncology | January 31, 2018 | By Emily Clemons
Technological and scientific advances in radiation oncology are allowing practitioners to put patients first in...
Overlay Init